Quest Diagnostics to Acquire Outreach Laboratory Services of OhioHealth
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX) announced an agreement to acquire select outreach laboratory services from OhioHealth, aiming to broaden access to cost-effective and innovative lab services in Ohio. The deal is expected to close in Q3 2024, pending customary regulatory reviews. OhioHealth will continue to operate its hospital labs independently, while most outreach testing will transition to Quest's Pittsburgh lab. Quest aims to leverage its economies of scale to provide more affordable services and expand its presence in Ohio. Financial terms were not disclosed.
Positive
- Broadens access to cost-effective lab services in Ohio.
- Expands Quest's presence across Ohio.
- Leverages economies of scale for cost savings.
- Expected to generate growth through accretive outreach lab acquisitions.
Negative
- Financial details of the transaction were not disclosed.
News Market Reaction 1 Alert
On the day this news was published, DGX gained 1.51%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Goal to broaden access to cost-effective and innovative laboratory services in
The transaction will broaden access to cost-effective and innovative laboratory services in
"As healthcare transforms, we need to ensure we can continue to provide high-quality care to our patients that also provides them value. As a trusted industry leader, Quest has the specialization and scale to ensure our patients have continued access to high quality lab services that, in many cases, will be more affordable for patients," said Chris Clinton, President, OhioHealth Regional Market and former Vice President, Shared Services. "Our relationship with Quest is the right strategic step to enable us to continue to deliver exceptional care to improve the health of those we serve."
"Quest has the expertise and economies of scale to deliver meaningful cost savings in lab services, while our patients continue to access the high quality of care they have been accustomed to from OhioHealth," said Juanita Swickard, Interim Vice President, Shared Services, OhioHealth.
"Our transaction with OhioHealth exemplifies our ability to attract and collaborate with high quality health systems seeking to optimize their lab services," said Jim Davis, Chairman, CEO and President, Quest Diagnostics. "Health systems are increasingly turning to Quest because of our unique ability to deliver laboratory testing that is innovative, accessible and cost effective. This transaction also delivers on our strategy, which includes generating growth through accretive outreach lab acquisitions, and will extend our presence across
After the acquisition's close, most outreach testing performed by OhioHealth will transition to the Quest Diagnostics full-service laboratory in
The parties expect to complete the transaction in the third quarter of 2024, assuming customary regulatory reviews. Financial details of the transaction were not disclosed.
About OhioHealth
Based in
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-acquire-outreach-laboratory-services-of-ohiohealth-302193553.html
SOURCE Quest Diagnostics